HDAC1 and cancer: A structural comparison between the KBTBD4–UM171–LHC complex and the two LHC-bound KBTBD4 MB mutants reveals a notable convergent mechanism by which the molecular glue and the cancer mutations complement and optimize the suboptimal protein–protein interface between the E3 ligase and HDAC1 to drive their association.